PA8548401A1 - ANTIBACTERIAL AGENTS - Google Patents
ANTIBACTERIAL AGENTSInfo
- Publication number
- PA8548401A1 PA8548401A1 PA20028548401A PA8548401A PA8548401A1 PA 8548401 A1 PA8548401 A1 PA 8548401A1 PA 20028548401 A PA20028548401 A PA 20028548401A PA 8548401 A PA8548401 A PA 8548401A PA 8548401 A1 PA8548401 A1 PA 8548401A1
- Authority
- PA
- Panama
- Prior art keywords
- compounds
- antibacterial agents
- formula
- useful
- prepare
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA COMPUESTOS DE FORMULA (I): EN LA QUE R1-R6 y J Y K TIENEN CUALQUIERA DE LOS VALORES DEFINIDOS EN LA MEMORIA DESCRIPTIVA, Y SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, QUE SON UTILES COMO AGENTES ANTIBACTERIANOS. TAMBIEN SE DESCRIBEN COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN UNO O MAS COMPUESTOS DE FORMULA I, PROCEDIMIENTOS PARA PREPARAR COMPUESTOS DE FORMULA I E INTERMEDIOS UTILES PARA PREPARAR COMPUESTOS DE FORMULA I.THIS INVENTION PROVIDES FORMULA COMPOUNDS (I): IN WHICH R1-R6 and J AND K HAVE ANY OF THE VALUES DEFINED IN THE DESCRIPTIVE MEMORY, AND ARE PHARMACEUTICALLY ACCEPTABLE SALES OF THE SAME, WHICH ARE USEFUL AS ANTIBACTERIAL AGENTS. PHARMACEUTICAL COMPOSITIONS THAT INCLUDE ONE OR MORE FORMULA COMPOUNDS, PROCEDURES TO PREPARE FORMULA I COMPOUNDS AND USEFUL INTERMEDIATES TO PREPARE FORMULA I COMPOUNDS ARE ALSO DESCRIBED.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29924901P | 2001-06-19 | 2001-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8548401A1 true PA8548401A1 (en) | 2003-05-14 |
Family
ID=23153973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20028548401A PA8548401A1 (en) | 2001-06-19 | 2002-06-19 | ANTIBACTERIAL AGENTS |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1401830A2 (en) |
JP (1) | JP2005501021A (en) |
AU (1) | AU2002302894A1 (en) |
BR (1) | BR0210028A (en) |
CA (1) | CA2446963A1 (en) |
DO (1) | DOP2002000422A (en) |
GT (1) | GT200200104A (en) |
HN (1) | HN2002000150A (en) |
MX (1) | MXPA03009894A (en) |
PA (1) | PA8548401A1 (en) |
PE (1) | PE20030272A1 (en) |
SV (1) | SV2003001089A (en) |
WO (1) | WO2002102793A2 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0414319A (en) * | 2003-09-12 | 2006-11-07 | Warner Lambert Co | quinolone antibacterial agents |
JP2007511597A (en) * | 2003-11-18 | 2007-05-10 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | Antibacterial aminoquinazolidinone derivatives |
WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
CN103443085B (en) | 2011-03-14 | 2016-03-23 | 南京英派药业有限公司 | Quinazoline diones and application thereof |
TWI527800B (en) | 2011-04-01 | 2016-04-01 | 南京英派藥業有限公司 | 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof |
SG10201610416TA (en) | 2012-06-13 | 2017-01-27 | Incyte Corp | Substituted tricyclic compounds as fgfr inhibitors |
WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
SI2986610T1 (en) | 2013-04-19 | 2018-04-30 | Incyte Holdings Corporation | Bicyclic heterocycles as fgfr inhibitors |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (en) | 2015-02-20 | 2017-12-26 | Incyte Corp | BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS |
MX2020004108A (en) | 2015-02-20 | 2022-01-03 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors. |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
CL2015003780A1 (en) | 2015-12-30 | 2016-09-16 | Univ Chile | Pyrimido-isoquinolin-quinone derivative compounds, their salts, isomers, acceptable pharmaceutical tautomers; farm compositions; preparation procedure; and its use in the treatment of multiresistant bacterial and bacterial diseases. |
AR111960A1 (en) | 2017-05-26 | 2019-09-04 | Incyte Corp | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR ITS PREPARATION |
JP7453148B2 (en) | 2018-02-16 | 2024-03-19 | サノビオン ファーマシューティカルズ インク | Salts, crystalline forms, and their production methods |
TW201946630A (en) | 2018-05-04 | 2019-12-16 | 美商英塞特公司 | Salts of an FGFR inhibitor |
WO2019213544A2 (en) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Solid forms of an fgfr inhibitor and processes for preparing the same |
CN111620866A (en) * | 2019-02-27 | 2020-09-04 | 南京药石科技股份有限公司 | Cis-7, 7-difluoro-hexahydro-1H pyrrolo [3,4-c ] pyridine derivative and preparation method thereof |
US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
IL291901A (en) | 2019-10-14 | 2022-06-01 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
WO2021113462A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Derivatives of an fgfr inhibitor |
EP4069696A1 (en) | 2019-12-04 | 2022-10-12 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
CN115734785A (en) | 2020-04-14 | 2023-03-03 | 桑诺维恩药品公司 | (S) - (4, 5-dihydro-7H-thieno [2,3-c ] pyran-7-yl) -N-methylmethanamine for the treatment of neurological and psychiatric disorders |
US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1311573A (en) * | 1970-04-27 | 1973-03-28 | Hisamitsu Pharmaceutical Co | Quinazolinedione derivatives |
GB1401549A (en) * | 1972-07-07 | 1975-07-16 | Hisamitsu Pharmaceutical Co | Pyrido-2,3-d-pyrimidine-2,4-1h,3h- diones and methods of preparing them |
JPS5758347B2 (en) * | 1974-04-03 | 1982-12-09 | Hisamitsu Pharmaceutical Co | |
JPS5761743B2 (en) * | 1974-04-25 | 1982-12-25 | Hisamitsu Pharmaceutical Co | |
DE2446543A1 (en) * | 1974-09-28 | 1976-04-15 | Hoechst Ag | Monoazomethine pigments - from 3-hydroxy 4-formylnaphthalic acid or derivs. |
DE2614148A1 (en) * | 1976-04-02 | 1977-10-20 | Henkel & Cie Gmbh | OXIDIZING AGENTS, BLEACHING AGENTS AND DETERGENTS WITH A BLEACH ACTIVATOR CONTENT |
IT1228293B (en) * | 1989-02-06 | 1991-06-07 | Angeli Inst Spa | BENZODERIVATES OF HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN. |
AU5813394A (en) * | 1992-12-23 | 1994-07-19 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Anellated uracil derivates |
JPH09208543A (en) * | 1995-11-29 | 1997-08-12 | Ono Pharmaceut Co Ltd | Production of isocyanate derivative and its related compound |
WO1997024335A1 (en) * | 1995-12-28 | 1997-07-10 | Fuji Chemical Industry Co., Ltd. | Process for the preparation of 3-dihalobenzyl-2,4-quinazolinedione derivatives |
DE69701647T2 (en) * | 1996-02-01 | 2000-09-07 | Sumitomo Chemical Co | Process for the preparation of dioxoquinazolines |
JPH09295977A (en) * | 1996-04-30 | 1997-11-18 | Terumo Corp | Pyridopyrimidine derivative and medicinal composition containing the same |
AU6908398A (en) * | 1996-10-28 | 1998-05-22 | Versicor Inc | Fused 2,4-pyrimidinedione combinatorial libraries and biologically active fused 2,4-pyramidinediones |
US6331538B1 (en) * | 1997-10-28 | 2001-12-18 | Warner-Lambert Company | 7-substituted quinazolin-2,4-diones useful as antibacterial agents |
MXPA02005989A (en) * | 2000-01-24 | 2002-10-23 | Warner Lambert Co | 3 aminoquinazolin 2,4 dione antibacterial agents. |
WO2001079206A1 (en) * | 2000-04-18 | 2001-10-25 | Sumitomo Pharmaceuticals Company, Limited | Tricyclic quinazolinediones |
JP2002284699A (en) * | 2001-03-28 | 2002-10-03 | Sumitomo Pharmaceut Co Ltd | Curative for visual cell degenerative disease |
-
2002
- 2002-05-13 BR BR0210028-2A patent/BR0210028A/en not_active IP Right Cessation
- 2002-05-13 AU AU2002302894A patent/AU2002302894A1/en not_active Abandoned
- 2002-05-13 EP EP02730582A patent/EP1401830A2/en not_active Withdrawn
- 2002-05-13 CA CA002446963A patent/CA2446963A1/en not_active Abandoned
- 2002-05-13 MX MXPA03009894A patent/MXPA03009894A/en unknown
- 2002-05-13 JP JP2003506266A patent/JP2005501021A/en not_active Withdrawn
- 2002-05-13 WO PCT/IB2002/001768 patent/WO2002102793A2/en not_active Application Discontinuation
- 2002-05-31 GT GT200200104A patent/GT200200104A/en unknown
- 2002-06-18 HN HN2002000150A patent/HN2002000150A/en unknown
- 2002-06-18 SV SV2002001089A patent/SV2003001089A/en unknown
- 2002-06-18 PE PE2002000523A patent/PE20030272A1/en not_active Application Discontinuation
- 2002-06-19 DO DO2002000422A patent/DOP2002000422A/en unknown
- 2002-06-19 PA PA20028548401A patent/PA8548401A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HN2002000150A (en) | 2002-09-13 |
JP2005501021A (en) | 2005-01-13 |
DOP2002000422A (en) | 2002-12-30 |
CA2446963A1 (en) | 2002-12-27 |
AU2002302894A1 (en) | 2003-01-02 |
PE20030272A1 (en) | 2003-03-21 |
BR0210028A (en) | 2004-06-22 |
EP1401830A2 (en) | 2004-03-31 |
MXPA03009894A (en) | 2004-02-17 |
WO2002102793A2 (en) | 2002-12-27 |
SV2003001089A (en) | 2003-03-18 |
WO2002102793A3 (en) | 2003-04-10 |
GT200200104A (en) | 2003-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8548401A1 (en) | ANTIBACTERIAL AGENTS | |
PA8631601A1 (en) | NEW COMPOUNDS | |
PA8559101A1 (en) | INHIBITORS OF THE XA FACTOR AND THE OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION WATERFALL | |
PA8553701A1 (en) | ANTIDIABETIC AGENTS | |
CR7956A (en) | INTERMEDIATE ANTIBACTERIAL INDOLONA OXAZOLIDINONES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
PA8577101A1 (en) | NEW DERIVATIVES OF THIOPHEN GLYCOSIDE, PROCEDURES FOR THE PREPARATION OF THE SAME, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THE SAME | |
ATE433447T1 (en) | PYRIMIIDINE COMPOUNDS | |
ECSP066643A (en) | PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS AS PDE 2 INHIBITORS | |
UY27350A1 (en) | AZAINDOLS | |
CL2011001658A1 (en) | Sulfonamide derivatives, sodium channel modulators; pharmaceutical composition comprising them; and its use in the treatment of pain. | |
CU20090184A7 (en) | AMINO-HETEROCYCLIC COMPOUNDS | |
CR10304A (en) | TETRAHYDROPIRIDOTIENOPIRIMIDINE COMPOUNDS AND PROCEDURES FOR THE SAME USE | |
PE20081506A1 (en) | ANSAMYCIN FORMULATIONS | |
SV2007002526A (en) | DIARILSULFONA SULFONAMIDS AND THE USE OF THE SAME REF. P1018 | |
UY29412A1 (en) | N-SULFONYLAMINOFENILETIL-2-PHENOXYACETAMIDE SUBSTITUTED COMPOUNDS. | |
GT200700096A (en) | PIRAZOLINE COMPOUNDS | |
CL2003002769A1 (en) | TIAZOLILPIRROL CARBOXAMIDE DERIVATIVE COMPOUNDS; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM; AND ITS USE FOR THE TREATMENT AND / OR PROFILAXIS OF DISEASES ASSOCIATED WITH THE CANABINOID RECEPTORS MODULATION | |
DE602004020070D1 (en) | THIENOPYRIMIDINE DERIVATIVES AS KALIUM CHANNEL INHIBITORS | |
SV2004001548A (en) | DIFENILAZETIDINONAS REPLACED IN ACID GROUP, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE | |
ECSP088967A (en) | MUSCARINIC RECEIVER AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA | |
ECSP088966A (en) | MUSCARINIC RECEIVER AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA | |
UY29999A1 (en) | "N-PIRAZINIL-PHENYLSULPHONAMIDS, PROCEDURES AND COMPOUNDS AVERAGE USED IN ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS" | |
PA8589801A1 (en) | AMINOALCOXYINDOLS | |
PA8661101A1 (en) | ANTIHELMINTIC COMPOUNDS | |
UY27514A1 (en) | BASIC LINEAR COMPOUNDS THAT HAVE NK-2 ANTAGONIST ACTIVITY AND ITS FORMULATIONS. |